Drs. Atkins and Agatston, You Were So Right

On January 20, I joined the ranks of those who've sacrificed themselves for science: I started one of those "low-carb" diets. So far, the sacrifice has been worth it.I'd always resisted celebrity-sponsored diets, smugly thinking my background in genetics and biochemistry made me more of an authority on matters nutritional than the likes of Whoopi Goldberg and Sarah Ferguson. I've even taught the subject.But this low-carb diet is different. It prescribes "good carbs and good fats" while blacking

Written byRicki Lewis
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

On January 20, I joined the ranks of those who've sacrificed themselves for science: I started one of those "low-carb" diets. So far, the sacrifice has been worth it.

I'd always resisted celebrity-sponsored diets, smugly thinking my background in genetics and biochemistry made me more of an authority on matters nutritional than the likes of Whoopi Goldberg and Sarah Ferguson. I've even taught the subject.

But this low-carb diet is different. It prescribes "good carbs and good fats" while blacking out most things white and processed, including rice, bread, pasta, and potatoes. Building on conventional wisdom about the evils of excess starch, this program also considers insulin swings.

A new way of viewing carbohydrates began in 1981, when a University of Toronto team measured the glycemic index (GI) for many foods. The GI is a measure of the speed at which foods hike blood glucose and therefore insulin secretion, averaged ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies